Butanilicaine phosphate
- Level
- Commodity
- Parent
- 51271600
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51271625This classification denotes an anesthetic agent with the molecular formula C13H19CLN2O.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JOZ20TRV0N. European Medicines Agency schedules butanilicaine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00912MIG. The term butanilicaine phosphate is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule butanilicaine phosphate under HS 29242995 and SITC 51479. As of Q4 2014, BUTANILICAINE PHOSPHATE remains US FDA's Preferred Term for this commodity. Butanilicaine phosphate bears US NLM identifiers UMLS ID C0888854 and NCI Concept Code C97305. SMILES: CCCCNCC(=O)NC1C(CCCC1CL)C.OP(=O)(O)O.
Same parent
Under 51271600 · 36Activities that produce or sell this
KBLI · 8Inherited from family 51270000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.